Do older Patients with a low Risk Profile (T1-2 [<3 cm] N0, HR +) need an adjuvant Radiotherapy for Breast Cancer, if they get Tamoxifen? - a Meta-Analysis of randomized Studies

被引：0
|
作者：
Matuschek, C. [1 ]
Boelke, E. [1 ]
Kammers, K. [2 ]
Budach, W. [1 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Abt Strahlentherapie & Radiol Onkol, Dusseldorf, Germany
[2] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V12-1
引用
收藏
页码：30 / 31
页数：2
相关论文
共 22 条
  • [1] Do patients with low-risk (T1-2 [<3 cm] N0, HR+) breast cancer and anti-hormone treatment need adjuvant radiation therapy? A meta-analysis of randomized trials.
    Matuschek, Christiane
    Boelke, Edwin
    Kammers, Kai
    Budach, Wilfried
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] PATIENTS WITH LOW-RISK BREAST CANCER AND TAMOXIFEN - DO THEY NEED ADJUVANT RADIATION THERAPY- A META-ANALYSIS
    Matuschek, Christiane
    Boelke, Edwin
    Kammers, Kai
    Budach, Wilfried
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S45 - S45
  • [3] Highly conformal radiotherapy for T1-2 n0 (=3 cm, <50% of the anal circumference) anal cancers: outcome and toxicity
    Lestrade, L.
    De Bari, B.
    Kountouri, M.
    Jumeau, R.
    Ozsahin, M.
    Zilli, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S660 - S661
  • [4] The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials
    Christiane Matuschek
    Edwin Bölke
    Jan Haussmann
    Svjetlana Mohrmann
    Carolin Nestle-Krämling
    Peter Arne Gerber
    Stefanie Corradini
    Klaus Orth
    Kai Kammers
    Wilfried Budach
    [J]. Radiation Oncology, 12
  • [5] Prognostic significance of TGFβ-1 and pSmad2/3 in breast cancer patients with T1-2,N0 tumours
    Koumoundourou, Dimitra
    Kassimatis, Theodoros
    Zolota, Vasiliki
    Tzorakoeleftherakis, Evangelos
    Ravazoula, Panagiota
    Vassiliou, Vassilios
    Kardamakis, Dimitrios
    Varakis, John
    [J]. ANTICANCER RESEARCH, 2007, 27 (4C) : 2613 - 2620
  • [6] Hemithyroidectomy versus total thyroidectomy for well differentiated T1-2 N0 thyroid cancer: systematic review and meta-analysis
    Rodriguez Schaap, P. M.
    Botti, M.
    Otten, R. H. J.
    Dreijerink, K. M. A.
    Nieveen van Dijkum, E. J. M.
    Bonjer, H. J.
    Engelsman, A. F.
    Dickhoff, C.
    [J]. BJS OPEN, 2020, 4 (06): : 987 - 994
  • [7] Post mastectomy radiotherapy for elderly patients with intermediate risk (T1-2N1 OR T3N0) breast cancer: a systematic review and meta-analysis
    Tseng, Michelle
    Vellayappan, Balamurugan
    Choong, Rachel
    Appalanaido, Gokula Kumar
    Soon, Yu Yang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S23 - +
  • [8] The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta- analysis of randomized trials
    Matuschek, Christiane
    Boelke, Edwin
    Haussmann, Jan
    Mohrmann, Svjetlana
    Nestle-Kraemling, Carolin
    Gerber, Peter Arne
    Corradini, Stefanie
    Orth, Klaus
    Kammers, Kai
    Budach, Wilfried
    [J]. RADIATION ONCOLOGY, 2017, 12
  • [9] Selecting patients with T1-2 breast cancer and 1-3 positive nodes at high locoregional recurrence risk for adjuvant radiotherapy.
    Truong, PT
    Olivotto, IA
    Kader, HA
    Panades, M
    Speers, CH
    Berthelet, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S170 - S170
  • [10] Most Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Do Not Need Post-Mastectomy Radiotherapy
    Muhsen, S.
    Patil, S.
    Stempel, M.
    Powell, S.
    Morrow, M.
    El-Tamer, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S21 - S22
123